Dicronis raises €105K Bridge round

3 July 2017· Zurich, Switzerland· health, diagnostics, biotech, wearable_technology, software_hardware, b2b

The loan will be employed in the bring-to-market of Dicronis's first product, Lymphit.

Investors

LeadVolkswirtschaftstiftung

About Dicronis

Stage
Pre-Seed
Headquarters
Zurich, Switzerland
Founded
2016
Team Size
6–20
Sectors
healthdiagnosticsbiotechwearable_technologysoftware_hardwareb2b

Source: https://www.dicronis.com/news_4